薄い子宮内膜およびアッシャーマン症候群における幹細胞療法:システマティックレビューおよびメタアナリシス
Leila Adamyan1, Laura Pivazyan2, Maria Yurkanova3
1National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Moscow 117997, Russia; Department of Obstetrics, Gynecology and Reproductive Medicine, Russian University of Medicine, Moscow 127473, Russia.
European journal of obstetrics, gynecology, and reproductive biology
|January 30, 2026
まとめ
間葉系幹細胞(MSC)療法は、子宮内膜菲薄またはアッシャーマン症候群の女性において、子宮内膜の厚さと生殖転帰を著しく改善しました。安全性は確認されていますが、子宮内膜再生の効果を確認するには、より大規模な試験が必要です。
関連する概念動画
Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K


